Roy L. Silverstein
Impact in
- Immunology top 0.1%
- Atherosclerosis and Cardiovascular Diseases
- Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research
Papers in
- Hematology 58
- Platelet Disorders and Treatments 36
- Blood Coagulation and Thrombosis Mechanisms 26
-
- Cell Adhesion Molecules Research 25
- Co-authors
- Maria FebbraioDavid P. HajjarRalph L. NachmanS. Frieda A. PearceStanley L. HazenEugene A. PodrezHenry F. HoffNoël Bouck
- Journals
- Journal of Clinical Investigation (21 papers)Journal of Biological Chemistry (20 papers)Arteriosclerosis Thrombosis and Vascular Biology (15 papers)Blood (15 papers)The Journal of Experimental Medicine (8 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Roy L. Silverstein
208 papers receiving 23.6k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Immunology 7.8k
- Immunology and Allergy 1.6k
- Cancer Research 3.6k
- Hematology 2.6k
- Molecular Biology 11.7k
Countries citing papers authored by Roy L. Silverstein
This map shows the geographic impact of Roy L. Silverstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy L. Silverstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy L. Silverstein more than expected).
Fields of papers citing papers by Roy L. Silverstein
This network shows the impact of papers produced by Roy L. Silverstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy L. Silverstein. The network helps show where Roy L. Silverstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roy L. Silverstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 38 | |
| 6 | 2021 | 13 | |
| 7 | 2020 | 26 | |
| 8 | 2020 | 7 | |
| 9 | 2013 | 60 | |
| 10 | Abstract 16993: Thrombospondin 1/CD36 Signaling Promotes Vascular Smooth Muscle Cell Proliferation and Contributes to Neointimal Hyperplasia | 2012 | 1 |
| 11 | 2009 | 98 | |
| 12 | 2009 | 126 | |
| 13 | Abstract 2635: Prothrombotic Disorders, Patent Foramen Ovale and Unexplained Cerebral Infarction: The THrombophilia in Cryptogenic StroKe (THICK) Study | 2008 | 1 |
| 14 | 2004 | 318 | |
| 15 | 2001 | 87 | |
| 16 | 2000 | 354 | |
| 17 | 2000 | 102 | |
| 18 | Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice Hit paper breakdown → | 2000 | 816 |
| 19 | 1982 | 2 | |
| 20 | 1982 | 7 |
About Roy L. Silverstein
Roy L. Silverstein is a scholar working on Hematology, Immunology and Allergy, Cancer Research, Immunology and Molecular Biology, having authored 209 papers that have together received 24.0k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (48 papers), Platelet Disorders and Treatments (36 papers), Angiogenesis and VEGF in Cancer (35 papers), Protease and Inhibitor Mechanisms (32 papers), Blood Coagulation and Thrombosis Mechanisms (26 papers), Atherosclerosis and Cardiovascular Diseases (25 papers), Cell Adhesion Molecules Research (25 papers) and Cancer, Lipids, and Metabolism (20 papers). The work is most often cited by research in Immunology (7.8k citations), Immunology and Allergy (1.6k citations), Cancer Research (3.6k citations), Hematology (2.6k citations) and Molecular Biology (11.7k citations). Roy L. Silverstein has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Maria Febbraio, David P. Hajjar, Ralph L. Nachman, S. Frieda A. Pearce, Stanley L. Hazen, Eugene A. Podrez, Henry F. Hoff, Noël Bouck, Nada A. Abumrad and Kavita Sharma. Their work appears in journals such as Journal of Clinical Investigation, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology, Blood and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.